The molecular pathology of Alzheimer’s disease
Authors:
- Darran YatesDYDarran Yates
- Declan M. McLoughlinDMDeclan M. McLoughlin
- 1 January 2008
- journal article
- Published by Elsevier in Psychiatry
- Vol. 7 (1) , 1-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Tau-mediated neurodegeneration in Alzheimer's disease and related disordersNature Reviews Neuroscience, 2007
- Alzheimer's disease: The amyloid cascade hypothesis: An update and reappraisalJournal of Alzheimer’s Disease, 2006
- The current status of Alzheimer?s disease genetics: what do we tell the patients?Pharmacological Research, 2004
- Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17Nature, 1998
- Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In VivoNeuron, 1996
- Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's diseaseNature Medicine, 1996
- Apolipoprotein E polymorphism and Alzheimer's diseaseThe Lancet, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991
- AN ANALYSIS OF THE MORPHOLOGY OF SENILE PLAQUES IN DOWN'S SYNDROME PATIENTS OF DIFFERENT AGES USING IMMUNOCYTOCHEMICAL AND LECTIN HISTOCHEMICAL TECHNIQUESNeuropathology and Applied Neurobiology, 1989